| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 11.66▼ | 11.78▼ | 11.78▼ | 12.02▼ | 13.43▼ |
| MA10 | 11.91▼ | 12.19▼ | 12.26▼ | 12.68▼ | N/A |
| MA20 | 12.38▼ | 12.37▼ | 12.29▼ | 13.55▼ | N/A |
| MA50 | 12.26▼ | 12.38▼ | 12.87▼ | N/A | N/A |
| MA100 | 12.23▼ | 13.15▼ | 13.40▼ | N/A | N/A |
| MA200 | 13.01▼ | 13.96▼ | 14.45▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.144▼ | -0.121▼ | -0.076▼ | -0.159▼ | N/A |
| RSI | 32.874▼ | 33.349▼ | 35.663▼ | 33.475▼ | N/A |
| STOCH | 1.845▼ | 0.762▼ | 7.404▼ | 28.112 | N/A |
| WILL %R | -95.429▼ | -95.455▼ | -95.455▼ | -80.847▼ | N/A |
| CCI | -109.474▼ | -141.169▼ | -139.100▼ | -144.770▼ | N/A |
|
Thursday, March 26, 2026 04:13 AM
AGMB-447 is an investigational drug and not approved by any regulatory authority. Its efficacy and safety have not been established.
|
|
Monday, February 09, 2026 01:04 PM
ANTWERP, Belgium, February 9, 2026 (GLOBE NEWSWIRE) – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying ...
|
|
Thursday, February 05, 2026 04:33 PM
ANTWERP, Belgium, February 5, 2026 (GLOBE NEWSWIRE) – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/03/26 | 11.37 | 11.45 | 11.37 | 11.45 | 8,063 |
| 26/03/26 | 12.70 | 13.56 | 11.71 | 11.87 | 124,279 |
| 25/03/26 | 11.93 | 13.49 | 11.755 | 12.86 | 137,811 |
| 24/03/26 | 12.37 | 12.93 | 10.50 | 11.645 | 439,687 |
| 23/03/26 | 12.33 | 13.2338 | 12.20 | 12.25 | 106,102 |
| 20/03/26 | 12.62 | 13.8085 | 11.78 | 12.19 | 177,906 |
| 19/03/26 | 13.71 | 14.63 | 12.61 | 12.70 | 445,557 |
| 18/03/26 | 13.75 | 14.12 | 13.37 | 13.85 | 53,203 |
| 17/03/26 | 14.29 | 14.59 | 13.20 | 13.71 | 147,528 |
| 16/03/26 | 14.19 | 14.50 | 14.00 | 14.315 | 67,169 |
|
|
||||
|
|
||||
|
|